Patent application number | Description | Published |
20090327905 | INTEGRATED CLIENT FOR ACCESS TO REMOTE RESOURCES - Techniques for discovering, connecting to, disconnecting from, reconnecting to, updating, and removing workspaces are described. In one embodiment, a list of discovered workspaces is maintained on a user device. Shortcuts for resources corresponding to each respective one of the discovered workspaces are integrated into a user interface of the user device. A request to access one of the resources contained in one of the discovered workspaces is received. Responsive to receiving the request, a connection from the user device to one or more resource hosts containing the resources corresponding to the indicated one of the discovered workspaces is opened. Access from the user device to the resources stored on the resource host(s) corresponding to the indicated one of the discovered workspaces is enabled by presenting shortcuts for resources corresponding to the discovered workspaces as though they were local resources. | 12-31-2009 |
20120084369 | Unified Reconnection To Multiple Remote Servers - Techniques are disclosed for connecting a user to all of his resources (e.g. remote desktop or remote application) in a deployment of server farm(s). The user's client sends a message to the deployment requesting any disconnected resources for the user and/or any active resources communicating with a different client. The deployment determines what those resources are, then strips out redundant information (e.g. two resources are remote applications executing within the same session) and sends a stripped list to the client, which reconnects. The client first reconnects to a resource that is not a VM and stores any user input (e.g. credentials) prompted for during that log in. Then, it reconnects to the other resources in parallel, using in these later reconnections any input received from the client during the first reconnection. | 04-05-2012 |
20130151706 | RESOURCE LAUNCH FROM APPLICATION WITHIN APPLICATION CONTAINER - A remote resource application that is associated with an application container in a manner that the application container restricts the remote resource application from directly accessing at least a file system of the computing system. The remote resource application provides a visualization for each of multiple remote resources. The user may launch the remote resource by selecting the corresponding visualization. Some of the remote resources are accessed by launching from the remote resource application itself in the context of the application container. Others of the remote resources are launched outside of the application container. The remote desktop application may operate securely within the application container, and still serve as an integrated location from which a user can access remote resources, regardless of whether the remote resource is launched from internal or external to the application container. | 06-13-2013 |
Patent application number | Description | Published |
20120183613 | Novel Pharmaceutical Composition - Disclosed are novel pharmaceutical compositions containing N-{3-[3-cyclopropyl-5-(2-fluoro-4-iodo-phenylamino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydro-2H-pyrido[4,3-d]pyrimidin-1-yl]phenyl}acetamide dimethyl sulfoxide solvate, methods of using the compositions in therapy and processes for preparing the same. | 07-19-2012 |
20130266649 | NOVEL PHARMACEUTICAL COMPOSITION - Disclosed are novel pharmaceutical compositions containing N-{3-[3-cyclopropyl-5-(2-fluoro-4-iodo-phenylamino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydro-2H-pyrido[4,3-d]pyrimidin-1-yl]phenyl}acetamide dimethyl sulfoxide solvate, methods of using the compositions in therapy and processes for preparing the same. | 10-10-2013 |
20140037726 | NOVEL PHARMACEUTICAL COMPOSITION - Disclosed are novel pharmaceutical compositions containing N-{3-[3-cyclopropyl-5-(2-fluoro-4-iodo-phenylamino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydro-2H-pyrido[4,3-d]pyrimidin-1-yl]phenyl}acetamide dimethyl sulfoxide solvate, methods of using the compositions in therapy and processes for preparing the same. | 02-06-2014 |
20140099365 | NOVEL PHARMACEUTICAL COMPOSITION - Disclosed are novel pharmaceutical compositions containing N-{3-[3-cyclopropyl-5-(2-fluoro-4-iodo-phenylamino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydro-2H-pyrido[4,3-d]pyrimidin-1-yl]phenyl}acetamide dimethyl sulfoxide solvate, methods of using the compositions in therapy and processes for preparing the same. | 04-10-2014 |
20140154316 | NOVEL PHARMACEUTICAL COMPOSITION - Disclosed are novel pharmaceutical compositions containing N-{3-[3-cyclopropyl-5-(2-fluoro-4-iodo-phenylamino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydro-2H-pyrido[4,3-d]pyrimidin-1-yl]phenyl}acetamide dimethyl sulfoxide solvate, methods of using the compositions in therapy and processes for preparing the same. | 06-05-2014 |
Patent application number | Description | Published |
20100058686 | Prefabricated Insulation Wall Panels for Construction of Concrete Walls - Prefabricated insulation wall panels for construction of a concrete wall include two elongated studs, each having a planar web section and inner and outer flanges, and one or two insulation boards vertically disposed between the two studs. The web section includes multiple through-holes spaced apart in the body portion of the stud, disposed off center in a transverse direction and closer to the inner flange than to the outer flange. The insulation board is thinner than the width of the wed section. The inner surface of the insulation board is disposed against the inner flanges of the studs, with two side edges of the insulation board covering the through-holes on the web section of each stud, thus establishing a distance between the outer surface of the insulation board and the outer flanges of the studs through the body portion of the studs. | 03-11-2010 |
20130019549 | Prefabricated Insulation Wall Panels for Construction of Walls - A prefabricated insulation wall panel for construction of a wall includes two elongated studs, each having a planar web section and inner and outer flanges, one or more insulation boards vertically disposed between the two studs, and one or more reinforcing mesh fastened to the flanges of the elongated studs on inner, outer or both sides of the wall panel. The reinforcing mesh has a preformed overhang section extending laterally beyond the elongated stud. The web section includes multiple through-holes spaced apart vertically, closer to the inner flange than to the outer flange. The insulation board is thinner than the width of the wed section, disposed with its inner surface against inner flanges of the studs and two side edges covering the through-holes on the web section of the stud, thus establishing a distance between the outer surface of the insulation board and the outer flanges of the studs. | 01-24-2013 |
Patent application number | Description | Published |
20100168806 | DEVICE AND METHOD FOR TREATING CARDIAC TISSUE OF A HEART OF A PATIENT WITH THERAPEUTIC LIGHT USING PHOTOBIOMODULATION - For treatment of cardiac tissue of a heart of a patient with therapeutic light using an implantable medical device connectable to at least one medical lead carrying electrodes and at least one fixation element that fixes the lead at a fixation area of the cardiac tissue, therapeutic light is emitted toward the at least one fixation area of cardiac tissue and/or toward a contact area between the at least one electrode and cardiac tissue using an intracorporeal light emitter. | 07-01-2010 |
20110040291 | TISSUE STIMULATING DEVICE AND METHOD - A tissue stimulating device that provides a biological stimulation of tissue has a release surface adapted for arrangement adjacent to a tissue to be stimulated. An agent reservoir of the device includes an ionic agent capable of causing a stimulation if present at sufficient high extracellular concentration close to the tissue. An agent releaser is provided in the device for releasing a selected amount of the ionic agent from the agent reservoir to an outside of the release surface at a stimulation occasion for stimulating the tissue. The ionic agent will cause a temporary change in ion permeability of the tissue cell membranes and a depolarization of the tissue cells. | 02-17-2011 |
20110245646 | MEDICAL IMPLANTABLE LEAD AND METHOD FOR THE MANUFACTURE THEREOF - A medical implantable lead adapted to be implanted into a human or animal body for monitoring and/or controlling of an organ inside the body has a fixation in a distal end, which is adapted to fix a distal end of the lead to the organ, an electrode member in the distal end adapted to be in contact with tissue of the organ and receive and/or transmit electrical signals from and/or to the organ, and at least one electrically conducting coil, which includes one or more electrically conducting helical wires and that is adapted to connect the electrode member in the distal end with a monitoring and/or controlling device in a proximal end of the lead. One or more of the individual wires of the coil has a wire core that is provided with a surrounding electrically insulating layer, which in turn is provided with a surrounding electrically conducting shield layer, and the coil is close lapped such that electrically conducting shield layers of adjacent loops of the coil are in electrical contact with each other. | 10-06-2011 |
20110251654 | ELECTRODE LEAD - An implantable electrode lead for tissue stimulation adapted to be attached to an implantable tissue stimulator provided with a pulse generator, has at least two stimulation electrodes to apply stimulation pulses to said tissue and arranged close to the distal end of the electrode lead, and at least two electrical conductors to connect said electrodes to said pulse generator. The electrode lead further has a switching unit arranged close to the distal end of the electrode lead and adapted to switch the electrode lead between a local pacing mode and a normal pacing mode, the switching unit being controlled by a mode control signal. Further, a pacing module is arranged close to the distal end of the electrode lead and in relation to the switching unit and being connectable to said at least two stimulation electrodes, the pacing module includes a pulse generating unit to generate stimulating pulses to be applied to the tissue by the stimulation electrodes. When the electrode lead is in the local pacing mode the electrical conductors are disconnected from said stimulation electrodes which instead are connected to the pacing module, and when the electrode lead is in the normal pacing mode the electrical conductors are connected to the stimulation electrodes. | 10-13-2011 |
20120035693 | IMPLANTABLE MRI COMPATIBLE MEDICAL LEAD - A medical implantable lead is adapted to be implanted into a human or animal body for monitoring and/or controlling of an organ inside the body, and has in a distal end, a combined fixation means and electrode member in form of a helix, which is rotatable in relation to the lead and extendable out from the distal end by rotation of a tubular torque transferring member. The helix is electrically connected to a connector in the proximal end by at least one electrically conducting wire, which is formed as an electrically conducting coil, which is separate from the tubular torque transferring member and that includes one or more individual wires each having an electrically conducting wire core and a surrounding electrically insulating layer. The tubular torque transferring member has no electrically conducting function to or from the helix. The lead is arranged such that the electrical connection between the helix and the conducting wire is always maintained regardless of the rotational position of the helix while no electrical connection is present between the helix and the tubular torque transferring member although the helix is rotatable by the tubular torque transferring member. | 02-09-2012 |
Patent application number | Description | Published |
20100016935 | MEDICAL IMPLANTABLE LEAD - A implantable lead an elongate body including a flexible insulating tube, and a tubular conductor layer formed of multiple separate strip conductors, which are arranged at the outer surface of the insulating tube and extend along the length thereof. | 01-21-2010 |
20100114279 | MEDICAL IMPLANTABLE LEAD - A medical implantable lead has a proximal end and a distal end, and a flexible flat elongate body. The elongate body includes a layer of strip conductors extending along the length of the flat elongate body, a top insulating layer, and a bottom insulating layer. The layer of strip conductors is sealingly enclosed between the top and bottom insulating layers, and at least a major portion of the flat elongate body is twisted into an elongate helical portion having a central cavity extending longitudinally of the helical portion. | 05-06-2010 |
20100280563 | DEVICE AND METHOD FOR DETECTING AND TREATING A MYOCARDIAL INFARCTION USING PHOTOBIOMODULATION - In an implantable medical device and a method for treating cardiac tissue of a heart of a patient with therapeutic light, a myocardial infarction is detected and a location the myocardial infarction is identified. A therapy session is initiated by selectively activating one or more of a number of light emitting units arranged in at least one medical lead connectable to the implantable medical device, to emit therapeutic light toward the detected location of the myocardial infarction upon detection of an occurrence of the myocardial infarction. | 11-04-2010 |